Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-03-04 18:29:44
Reporting Period:
Accepted Time:
2019-03-04 18:29:44
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1675878 S. Richard Shames C/o Protagonist Therapeutics, Inc.
7707 Gateway Boulevard, Suite 140
Newark CA 94560
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 8,500 $0.00 32,678 No 4 A Direct
Common Stock Disposition 2019-03-01 657 $8.03 32,021 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2019-02-28 51,000 $0.00 51,000 $8.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,000 2029-02-27 No 4 A Direct
  1. Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.
  2. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  3. The stock option vests in 48 equal monthly installments following the date of grant.